Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors.

Histopathology - 1 Mar 2018

Hoton Delphine, Humblet Yves, Libbrecht Louis

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Anaplastic Lymphoma Kinase
Share to Carcinoid Tumor
Share to Carcinoma, Large Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Neuroendocrine

Share to Lung Neoplasms

Share to Phenotype

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 28888040
DOI: 10.1111/his.13388

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors.PMID 28888040Read ↗

Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.Semantic proximity Read ↗

ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two casesSemantic proximity Read ↗

ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Series of Non-Asian Patients With Response to ALK Inhibitors.Semantic proximity Read ↗

Spontaneous Transformation from EGFR and ALK Wild-Type Lung Adenocarcinoma to Neuroendocrine Carcinoma.Semantic proximity Read ↗

Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinomaSemantic proximity Read ↗

Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas.Semantic proximity Read ↗

Clonally-related primary ALK rearranged adenocarcinoma and associated metastatic lesions.Semantic proximity Read ↗

Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitorSemantic proximity Read ↗

Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.Semantic proximity Read ↗

Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors.Semantic proximity Read ↗

Different histopathology but the same clonality: ALK rearrangement in a patient with metastatic non-small-cell lung cancer.Semantic proximity Read ↗

Large-cell neuroendocrine carcinoma with epidermal growth factor receptor mutation: possible transformation of lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.